Pexa-Vec (JX-594)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Pexa-Vec (JX-594), covering 2013-01-04 to 2015-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib [Phase 2]